SM
Slate Medicines, Inc.
SEC filingPharmaceuticals · Boston, MA
Amount raised$10Msold at filing
Total offering$130M$120M still open
Investors in the raise6count reported to the SEC
FiledMar 11, 2026first sale Feb 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sara PachecoExecutive Officer
Tim LohoffDirector
Cindy XiongDirector
Neil BuckleyExecutive Officer, Director
Gregory Frank OakesExecutive Officer
Andrew LevinDirector
Executive officers, directors and promoters as listed on the Form D.